Philippe Ravassard

Philippe Ravassard is a Project Leader and CNRS Researcher (CR1) leading Team MPP+ (Molecular Pathophysiology of Parkinson's Disease) at the Brain Institute (ICM), affiliated with Sorbonne University.

His academic background includes biochemistry training at École Normale Supérieure de Cachan, a doctorate in nervous system developmental biology under Jacques Mallet, and a postdoctoral fellowship at McGill University with Jean Pierre Julien. He obtained accreditation to supervise research (HDR) in 2014.

Ravassard pioneered the cloning of Neurogenin 3 (ngn3) in rats—a master regulator of pancreatic endocrine differentiation—and developed the first human pancreatic β-cell line secreting insulin in response to glucose, now the global reference for diabetes research. His current work applies next-generation sequencing and chromatin analysis to study long non-coding RNAs in both pancreatic β-cells and Parkinson's disease pathogenesis.

As scientific coordinator of PhenoParc and iVector platforms, he drives research on genomic regulation in cell differentiation. His NIH-funded projects investigate long non-coding RNA functions, bridging pancreatic development and neurodegenerative mechanisms.

Through his HDR accreditation, Ravassard mentors researchers in Team MPP+, co-led with Jean-Christophe Corvol. His lab focuses on molecular pathways in Parkinson's disease using advanced genomic platforms integrated within the Brain Institute's neuroscience ecosystem.